Identification of Novel Human Monocyte Subsets and Evidence for Phenotypic Groups Defined by Interindividual Variations of Expression of Adhesion Molecules von Merah-Mourah, F., Cohen, S. O., Charron, D., Mooney, N., Haziot, A.

Volltext

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers von INZELBERG, R, COHEN, O. S, INZELBERG, L, KAPLAN, N, FIXLER MEHR, T, MORY, A, DAGAN, E, SCHECHTMAN, E, FRIEDMAN, E, HASSIN-BAER, S, AHARON-PERETZ, J, SCHLESINGER, I, GERSHONI-BARUCH, R, DJALDETTI, R, NITSAN, Z, EPHRARY, L, TUNKEL, O, KOZLOVA, E

Volltext

A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples von Cohen, O S, Weickert, T W, Hess, J L, Paish, L M, McCoy, S Y, Rothmond, D A, Galletly, C, Liu, D, Weinberg, D D, Huang, X-F, Xu, Q, Shen, Y, Zhang, D, Yue, W, Yan, J, Wang, L, Lu, T, He, L, Shi, Y, Xu, M, Che, R, Tang, W, Chen, C-H, Chang, W-H, Hwu, H-G, Liu, C-M, Liu, Y-L, Wen, C-C, Fann, C S-J, Chang, C-C, Kanazawa, T, Middleton, F A, Duncan, T M, Faraone, S V, Weickert, C S, Tsuang, M T, Glatt, S J

Volltext

Cerebral White Matter Disruption in Creutzfeldt-Jakob Disease von LEE, H, COHEN, O. S, ROSENMANN, H, HOFFMANN, C, KINGSLEY, P. B, KORCZYN, A. D, CHAPMAN, J, PROHOVNIK, I

Volltext

The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression von Cohen, O. S., Prohovnik, I., Korczyn, A. D., Ephraty, L., Nitsan, Z., Tsabari, R., Appel, S., Rosenmann, H., Kahana, E., Chapman, J.

Volltext

The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia von Molchadski, I., Korczyn, A. D., Cohen, O. S., Katzav, A., Nitzan, Z., Chapman, J., Hassin-Baer, S.

Volltext

Pseudo‐anticipation in Creutzfeldt–Jakob disease is due to a rhomboid‐shaped artifact von Cohen, O. S., Kahana, E., Korczyn, A. D., Ziv‐Baran, T., Nitsan, Z., Appel, S., Rosenmann, H., Chapman, J.

Volltext

CSF tau correlates with CJD disease severity and cognitive decline von Cohen, O. S., Chapman, J., Korczyn, A. D., Warman-Alaluf, N., Nitsan, Z., Appel, S., Kahana, E., Rosenmann, H.

Volltext

Unusual presentations in patients with E200K familial Creutzfeldt−Jakob disease von Cohen, O. S., Kimiagar, I., Korczyn, A. D., Nitsan, Z., Appel, S., Hoffmann, C., Rosenmann, H., Kahana, E., Chapman, J.

Volltext

Seizures in E200K familial and sporadic Creutzfeldt-Jakob disease von Appel, S., Chapman, J., Cohen, O. S., Rosenmann, H., Nitsan, Z., Blatt, I.

Volltext

Exploring determinants of progression in Parkinson's disease. Is there a difference among Jewish ethnic groups? von Orlev, Y, Yahalom, G, Cohen, O.S, Elincx-Benizri, S, Kozlova, E, Inzelberg, R, Goldbourt, U, Hassin-Baer, S

Volltext

Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever von Appel, S. A., Chapman, J., Kahana, E., Rosenmann, H., Prohovnik, I., Pras, E., Reznik-Wolf, H., Cohen, O. S.

Volltext

Dance/Movement Therapy for Children and Adolescents with Cancer von Cohen, Susan O., Walco, Gary A.

Volltext

Asymmetric dopamine loss differentially affects effort to maximize gain or minimize loss von Porat, Omer, Hassin-Baer, Sharon, Cohen, Oren S., Markus, Andrey, Tomer, Rachel

Volltext

Enhanced creative thinking under dopaminergic therapy in Parkinson disease von Faust-Socher, Achinoam, Kenett, Yoed N., Cohen, Oren S., Hassin-Baer, Sharon, Inzelberg, Rivka

Volltext

THE LRRK2 G2019S MUTATION IS ASSOCIATED WITH PARKINSON DISEASE AND CONCOMITANT NON-SKIN CANCERS von Inzelberg, R, Cohen, O S, Aharon-Peretz, J, Schlesinger, I, Gershoni-Baruch, R, Djaldetti, R, Nitsan, Z, Ephraty, L, Tunkel, O, Kozlova, E, Inzelberg, L, Kaplan, N, Mehr, T F, Mory, A

Volltext

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitaz... von Marre, M., Shaw, J., Brändle, M., Bebakar, W. M. W., Kamaruddin, N. A., Strand, J., Zdravkovic, M., Le Thi, T. D., Colagiuri, S.

Volltext

The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia: Apolipoprotein E and levodopa-induced dyskinesia von Molchadski, I., Korczyn, A. D., Cohen, O. S., Katzav, A., Nitzan, Z., Chapman, J., Hassin-Baer, S.

Volltext

The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression: A new neurological scale for the evaluation of Creutzf... von Cohen, O. S., Prohovnik, I., Korczyn, A. D., Ephraty, L., Nitsan, Z., Tsabari, R., Appel, S., Rosenmann, H., Kahana, E., Chapman, J.

Volltext

EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents von Hoffmann, Luisa, Kohls, Mirjam, Arnolds, Stefanie, Achenbach, Peter, Bergholdt, Regine, Bonifacio, Ezio, Bosi, Emanuele, Gündert, Melanie, Hoefelschweiger, Bianca K, Hummel, Sandra, Jarosz-Chobot, Przemysława, Kordonouri, Olga, Lampasona, Vito, Narendran, Parth, Overbergh, Lut, Pociot, Flemming, Raposo, João Filipe, Šumník, Zdeněk, Szypowska, Agnieszka, Vercauteren, Jurgen, Winkler, Christiane, Mathieu, Chantal, Ziegler, Anette-Gabriele, Mathieu, C, Gillard, P, Casteels, K, van der Schueren, B, Overbergh, L, Vercauteren, J, Ziegler, A G, Achenbach, P, Haupt, F, Winkler, C, Hummel, S, Pieber, T, Mader, J, Moitzi, S, Del Prato, S, Torbeyns, B, Sumnik, Z, Cinek, O, Neuman, V, Berka, B, Pociot, F, Petersen, B, Antvorskov, J, Klaebel, J H, Lahesmaa, R, Hyöty, H, Laiho, J E, Reschke, F, Kordonouri, O, von dem Berge, T, Bonifacio, E, Berner, R, Hommel, A, Loff, A, Gemulla, G, Zubizarreta, N, Bosi, E, Piemonti, L, Lampasona, V, Dotta, F, Sebastiani, G, Szypowska, A, Karczewski, K, Jarosz-Chobot, P, Raposo, J F, Ribeiro, R, Coelho, R, Peakman, M, Niemoeller, E, Baccara-Dinet, M, Van Rampelbergh, J, Bergholdt, R, Fogh, K, Cohen, O, Buompensiere, M I, Hurtado del Pozo, C, Latres, E, Agiostratidou, G, Koralova, A

Volltext